Exact Mass: 505.20128900000003
Exact Mass Matches: 505.20128900000003
Found 143 metabolites which its exact mass value is equals to given mass value 505.20128900000003
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
alangiside
C25H31NO10 (505.19478660000004)
An organic heterotetracyclic compound that is an alkaloidal glycoside isolated from Alangium salviifolium.
3-O-demethyl-2-O-methylisoalangiside
C25H31NO10 (505.19478660000004)
Rocaglamide
Rocaglamide is an organic heterotricyclic compound that is 2,3,3a,8b-tetrahydro-1H-benzo[b]cyclopenta[d]furan substituted by hydroxy groups at positions 1 and 8b, methoxy groups at positions 6 and 8, a 4-methoxyphenyl group at position 3a, a phenyl group at position 3 and a N,N-dimethylcarbamoyl group at position 1. Isolated from Aglaia odorata and Aglaia duperreana, it exhibits antineoplastic activity. It has a role as a metabolite, an antineoplastic agent and an antileishmanial agent. It is an organic heterotricyclic compound, a monomethoxybenzene and a monocarboxylic acid amide. Rocaglamide, also referred to as rocaglamide-A, is the eponymous member of a class of anti-cancer phytochemicals known as rocaglamides. Rocaglamides are secondary metabolites of the plant genus Aglaia, and extracts of the plant have traditionally been used as a form of insect repellant due to its natural insecticidal properties. Reports of Aglaia anti-tumor activity date back as far as 1973, and rocaglamide-A was first isolated in 1982 from the species A. elliptifolia. Rocaglamide and a number of its derivatives (e.g. [didesmethylrocaglamide]) are currently being studied for use as chemotherapeutic agents in the treatment of various leukemias, lymphomas, and carcinomas, as well as adjuvant therapy in the treatment of certain chemotherapy-resistant cancers. Rocaglamide is a natural product found in Aglaia rimosa, Aglaia elliptifolia, and other organisms with data available. An organic heterotricyclic compound that is 2,3,3a,8b-tetrahydro-1H-benzo[b]cyclopenta[d]furan substituted by hydroxy groups at positions 1 and 8b, methoxy groups at positions 6 and 8, a 4-methoxyphenyl group at position 3a, a phenyl group at position 3 and a N,N-dimethylcarbamoyl group at position 1. Isolated from Aglaia odorata and Aglaia duperreana, it exhibits antineoplastic activity.
Cys Asn Asn Arg
Cys Asn Arg Asn
Cys Pro Thr Trp
C23H31N5O6S (505.19949460000004)
Cys Pro Trp Thr
C23H31N5O6S (505.19949460000004)
Cys Gln Gln Gln
Cys Arg Asn Asn
Cys Thr Pro Trp
C23H31N5O6S (505.19949460000004)
Cys Thr Trp Pro
C23H31N5O6S (505.19949460000004)
Cys Trp Pro Thr
C23H31N5O6S (505.19949460000004)
Cys Trp Thr Pro
C23H31N5O6S (505.19949460000004)
Asp Asp Glu Lys
Asp Asp Lys Glu
Asp Glu Asp Lys
Asp Glu Lys Asp
Asp Lys Asp Glu
Asp Lys Glu Asp
Glu Asp Asp Lys
Glu Asp Lys Asp
Glu Glu Gln Thr
Glu Glu Thr Gln
Glu Lys Asp Asp
Glu Gln Glu Thr
Glu Gln Thr Glu
Glu Thr Glu Gln
Glu Thr Gln Glu
Lys Asp Asp Glu
Lys Asp Glu Asp
Lys Glu Asp Asp
Met Met Pro Gln
C20H35N5O6S2 (505.20286500000003)
Met Met Gln Pro
C20H35N5O6S2 (505.20286500000003)
Met Asn Asn Gln
Met Asn Gln Asn
Met Pro Met Gln
C20H35N5O6S2 (505.20286500000003)
Met Pro Gln Met
C20H35N5O6S2 (505.20286500000003)
Met Gln Met Pro
C20H35N5O6S2 (505.20286500000003)
Met Gln Asn Asn
Met Gln Pro Met
C20H35N5O6S2 (505.20286500000003)
Asn Cys Asn Arg
Asn Cys Arg Asn
Asn Met Asn Gln
Asn Met Gln Asn
Asn Asn Cys Arg
Asn Asn Met Gln
Asn Asn Gln Met
Asn Asn Arg Cys
Asn Gln Met Asn
Asn Gln Asn Met
Asn Arg Cys Asn
Asn Arg Asn Cys
Pro Cys Thr Trp
C23H31N5O6S (505.19949460000004)
Pro Cys Trp Thr
C23H31N5O6S (505.19949460000004)
Pro Met Met Gln
C20H35N5O6S2 (505.20286500000003)
Pro Met Gln Met
C20H35N5O6S2 (505.20286500000003)
Pro Gln Met Met
C20H35N5O6S2 (505.20286500000003)
Pro Thr Cys Trp
C23H31N5O6S (505.19949460000004)
Pro Thr Trp Cys
C23H31N5O6S (505.19949460000004)
Pro Trp Cys Thr
C23H31N5O6S (505.19949460000004)
Pro Trp Thr Cys
C23H31N5O6S (505.19949460000004)
Gln Cys Gln Gln
Gln Glu Glu Thr
Gln Glu Thr Glu
Gln Met Met Pro
C20H35N5O6S2 (505.20286500000003)
Gln Met Asn Asn
Gln Met Pro Met
C20H35N5O6S2 (505.20286500000003)
Gln Asn Met Asn
Gln Asn Asn Met
Gln Pro Met Met
C20H35N5O6S2 (505.20286500000003)
Gln Gln Cys Gln
Gln Gln Gln Cys
Gln Thr Glu Glu
Arg Cys Asn Asn
Arg Asn Cys Asn
Arg Asn Asn Cys
Thr Cys Pro Trp
C23H31N5O6S (505.19949460000004)
Thr Cys Trp Pro
C23H31N5O6S (505.19949460000004)
Thr Glu Glu Gln
Thr Glu Gln Glu
Thr Pro Cys Trp
C23H31N5O6S (505.19949460000004)
Thr Pro Trp Cys
C23H31N5O6S (505.19949460000004)
Thr Gln Glu Glu
Thr Trp Cys Pro
C23H31N5O6S (505.19949460000004)
Thr Trp Pro Cys
C23H31N5O6S (505.19949460000004)
Trp Cys Pro Thr
C23H31N5O6S (505.19949460000004)
Trp Cys Thr Pro
C23H31N5O6S (505.19949460000004)
Trp Pro Cys Thr
C23H31N5O6S (505.19949460000004)
Trp Pro Thr Cys
C23H31N5O6S (505.19949460000004)
Trp Thr Cys Pro
C23H31N5O6S (505.19949460000004)
Trp Thr Pro Cys
C23H31N5O6S (505.19949460000004)
TERT-BUTYL ((S)-1-((S)-2-CARBAMOYLPYRROLIDIN-1-YL)-1-OXO-3-(1-TOSYL-1H-IMIDAZOL-4-YL)PROPAN-2-YL)CARBAMATE
C23H31N5O6S (505.19949460000004)
7-[(3S,5S)-3-amino-5-methylpiperidin-1-yl]-1-cyclopropyl-8-methoxy-4-oxoquinoline-3-carboxylic acid,2-hydroxybutanedioic acid
Nefazodone hydrochloride
D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D000068760 - Serotonin and Noradrenaline Reuptake Inhibitors D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent D049990 - Membrane Transport Modulators Nefazodone hydrochloride (BMY-13754) is a potent and selective 5HT2A (Ki=5.8 nM) antagonist with moderate inhibition of 5-HT and noradrenaline uptake (IC50 of 290 and 300 nM, respectively). Nefazodone hydrochloride is a phenylpiperazine antidepressant with less alpha-adrenergic blocking activity[1][2].
Adavivint
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor D000893 - Anti-Inflammatory Agents
N-[4-[[2-methoxy-5-[4-oxo-3-(phenylmethyl)-2-quinazolinyl]phenyl]methoxy]phenyl]acetamide
C31H27N3O4 (505.20014620000006)
(11S,12aR,13aR)-12-ethenyl-11-(beta-D-glucopyranosyloxy)-2-hydroxy-3-methoxy-5,6,12,12a,13,13a-hexahydro-11H-pyrano[4,3:4,5]pyrido[2,1-a]isoquinolin-8-one
C25H31NO10 (505.19478660000004)
(3S)-3-[[[(2S)-1-[(2S)-2-[[(4-amino-3-chlorophenyl)-oxomethyl]amino]-3,3-dimethyl-1-oxobutyl]-2-pyrrolidinyl]-oxomethyl]amino]-3-cyanopropanoic acid ethyl ester
C24H32ClN5O5 (505.20918520000004)
3-(3-fluorophenyl)-1-[[(4S,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-1-methylurea
3-(3-fluorophenyl)-1-[[(4R,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-1-methylurea
3-[(3aS,4S,9bS)-4-(hydroxymethyl)-1-(4-methylphenyl)sulfonyl-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]-N,N-dimethylbenzamide
C28H31N3O4S (505.20351660000006)
3-[(3aS,4R,9bS)-4-(hydroxymethyl)-1-(4-methylphenyl)sulfonyl-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]-N,N-dimethylbenzamide
C28H31N3O4S (505.20351660000006)
3-(3-fluorophenyl)-1-[[(4S,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-1-methylurea
3-(3-fluorophenyl)-1-[[(4S,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-1-methylurea
3-(3-fluorophenyl)-1-[[(4R,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-1-methylurea
2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(1-oxo-2-pyridin-4-ylethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(3-fluorophenyl)methyl]acetamide
C28H28FN3O5 (505.20128900000003)
3-(3-fluorophenyl)-1-[[(4R,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-1-methylurea
3-(3-fluorophenyl)-1-[[(4R,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-1-methylurea
3-(3-fluorophenyl)-1-[[(4S,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-1-methylurea
2-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(2-pyridin-4-ylacetyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-[(3-fluorophenyl)methyl]acetamide
C28H28FN3O5 (505.20128900000003)
2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-[(2-pyridin-4-ylacetyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-[(3-fluorophenyl)methyl]acetamide
C28H28FN3O5 (505.20128900000003)
3-[(3aR,4S,9bR)-4-(hydroxymethyl)-1-(4-methylphenyl)sulfonyl-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]-N,N-dimethylbenzamide
C28H31N3O4S (505.20351660000006)
3-(4-fluorophenyl)-1-[[(4R,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-1-methylurea
2-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-6-[(1-oxo-2-pyridin-4-ylethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(3-fluorophenyl)methyl]acetamide
C28H28FN3O5 (505.20128900000003)
2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-[(1-oxo-2-pyridin-4-ylethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(3-fluorophenyl)methyl]acetamide
C28H28FN3O5 (505.20128900000003)
3-[(3aR,4R,9bR)-4-(hydroxymethyl)-1-(4-methylphenyl)sulfonyl-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]-N,N-dimethylbenzamide
C28H31N3O4S (505.20351660000006)
(E)-N-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-3-[3-methoxy-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]prop-2-enamide
C25H31NO10 (505.19478660000004)
4,5-dimethoxy-2-{[(9s)-4,15,16-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-5-yl]oxy}benzaldehyde
(1s,2r,3r,3as,8as)-3,3a-dihydroxy-8a-(3-hydroxy-4-methoxyphenyl)-4,6-dimethoxy-n-methyl-1-phenyl-1h,2h,3h,8h-cyclopenta[a]indene-2-carboximidic acid
methyl 2-{14-[4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]-7,15-dihydroxy-4-methyl-2,10-dioxo-5,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),11,13-tetraen-6-yl}acetate
C25H31NO10 (505.19478660000004)
(2s,3s,4s,5s,6r)-2,3-dihydroxy-10,12-dimethoxy-6-(4-methoxyphenyl)-n,n-dimethyl-5-phenyl-7-oxatricyclo[6.4.0.0²,⁶]dodeca-1(12),8,10-triene-4-carboxamide
methyl 2-[(4r,6r,7s)-14-[(2r,4r,5s,6r)-4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]-7,15-dihydroxy-4-methyl-2,10-dioxo-5,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),11,13-tetraen-6-yl]acetate
C25H31NO10 (505.19478660000004)